Loading…

Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker

Gastric cancer is the second most common cause of cancer deaths worldwide and due to its poor prognosis, it is important that specific biomarkers are identified to enable its early detection. Through 2‐D gel electrophoresis and MALDI‐TOF‐TOF‐based proteomics approaches, we found that 14‐3‐3β, which...

Full description

Saved in:
Bibliographic Details
Published in:Proteomics (Weinheim) 2011-06, Vol.11 (12), p.2423-2439
Main Authors: Tseng, Chien-Wei, Yang, Jyh-Chin, Chen, Chiung-Nien, Huang, Hsuan-Cheng, Chuang, Kai-Neng, Lin, Chen-Ching, Lai, Hong-Shiee, Lee, Po-Huang, Chang, King-Jen, Juan, Hsueh-Fen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gastric cancer is the second most common cause of cancer deaths worldwide and due to its poor prognosis, it is important that specific biomarkers are identified to enable its early detection. Through 2‐D gel electrophoresis and MALDI‐TOF‐TOF‐based proteomics approaches, we found that 14‐3‐3β, which was one of the proteins that were differentially expressed by 5‐fluorouracil‐treated gastric cancer SC‐M1 cells, was upregulated in gastric cancer cells. 14‐3‐3β levels in tissues and serum were further validated in gastric cancer patients and controls. The results showed that 14‐3‐3β levels were elevated in tumor tissues (n=40) in comparison to normal tissues (n=40; p
ISSN:1615-9853
1615-9861
DOI:10.1002/pmic.201000449